Home
/
Citius Pharmaceuticals, Inc.
/
Financials
/
Quarterly
Citius Pharmaceuticals, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Citius Pharmaceuticals, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2026
Dec 31, 2025
$3.94M
Feb 13, 2026
Q3
2014
Jun 30, 2014
$0
Aug 14, 2014
Q2
2014
Mar 31, 2014
$0
May 15, 2014
Q1
2014
Dec 31, 2013
$0
Feb 19, 2014
Q2
2014
Sep 30, 2013
$0
May 15, 2014
Q3
2014
Jun 30, 2013
$0
Aug 14, 2014
Q2
2014
Mar 31, 2013
$0
May 15, 2014
Q1
2014
Dec 31, 2012
$0
Feb 19, 2014
Q3
2013
Jun 30, 2012
$0
Sep 18, 2013
Q2
2013
Mar 31, 2012
$0
May 13, 2013
Q1
2013
Dec 31, 2011
$0
Feb 8, 2013
Q3
2012
Jun 30, 2011
$0
Aug 17, 2012
Q2
2012
Mar 31, 2011
$0
May 11, 2012
Q1
2012
Dec 31, 2010
$0
Feb 14, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2025
Mar 31, 2025
($11.51M)
May 14, 2025
Q2
2025
Dec 31, 2024
($10.28M)
May 14, 2025
Q3
2024
Jun 30, 2024
($10.57M)
Aug 12, 2024
Q2
2025
Mar 31, 2024
($8.54M)
May 14, 2025
Q2
2025
Dec 31, 2023
$9.23M
May 14, 2025
Q1
2024
Dec 31, 2023
($9.23M)
Feb 14, 2024
Q3
2024
Jun 30, 2023
($8.48M)
Aug 12, 2024
Q2
2024
Mar 31, 2023
($10.53M)
May 14, 2024
Q1
2024
Dec 31, 2022
($3.59M)
Feb 14, 2024
Q3
2022
Jun 30, 2022
($8.86M)
Aug 11, 2022
Q2
2022
Mar 31, 2022
($7.56M)
May 12, 2022
Q1
2023
Dec 31, 2021
($9.23M)
Feb 10, 2023
Q3
2022
Jun 30, 2021
($5.82M)
Aug 11, 2022
Q2
2022
Mar 31, 2021
($4.12M)
May 12, 2022
Q1
2022
Dec 31, 2020
($8.15M)
Feb 10, 2022
Q3
2021
Jun 30, 2020
($4.68M)
Aug 12, 2021
Q2
2021
Mar 31, 2020
($4.42M)
May 13, 2021
Q1
2021
Dec 31, 2019
($4.32M)
Feb 11, 2021
Q3
2020
Jun 30, 2019
($4.41M)
Aug 14, 2020
Q2
2020
Mar 31, 2019
($3.63M)
May 14, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2026
Dec 31, 2025
($9.02M)
Feb 13, 2026
Q3
2025
Jun 30, 2025
($8.79M)
Aug 12, 2025
Q2
2025
Mar 31, 2025
($11.26M)
May 14, 2025
Q1
2026
Dec 31, 2024
($10.04M)
Feb 13, 2026
Q3
2025
Jun 30, 2024
($10.63M)
Aug 12, 2025
Q2
2025
Mar 31, 2024
($10.97M)
May 14, 2025
Q1
2025
Dec 31, 2023
($9.34M)
Feb 14, 2025
Q3
2024
Jun 30, 2023
($8.67M)
Aug 12, 2024
Q2
2024
Mar 31, 2023
($10.69M)
May 14, 2024
Q1
2024
Dec 31, 2022
($7.25M)
Feb 14, 2024
Q3
2023
Jun 30, 2022
($8.92M)
Aug 14, 2023
Q2
2023
Mar 31, 2022
($7.59M)
May 12, 2023
Q1
2023
Dec 31, 2021
($9.26M)
Feb 10, 2023
Q3
2022
Jun 30, 2021
($5.98M)
Aug 11, 2022
Q2
2022
Mar 31, 2021
($4.19M)
May 12, 2022
Q1
2022
Dec 31, 2020
($8.16M)
Feb 10, 2022
Q3
2021
Jun 30, 2020
($4.69M)
Aug 12, 2021
Q2
2021
Mar 31, 2020
($4.43M)
May 13, 2021
Q1
2021
Dec 31, 2019
($4.45M)
Feb 11, 2021
Q3
2020
Jun 30, 2019
($4.43M)
Aug 14, 2020